BCAB Competitors & Alternatives
Compare Bioatla Inc with similar stocks in the same industry
Biotechnology
BCAB
Main Stock$1.74
Tradestie Score
39
Market Cap
$39.57M
Revenue Growth
0.3%
Analyst Upside
+476.4%
Top Competitors
223 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
AVTX
Avalo Therapeutics, Inc. Common Stock
|
$7.76
|
$170.45M | - | 55 | Compare |
|
ACHV
Achieve Life Sciences, Inc.
|
$6.56
|
$158.43M | - | 59 | Compare |
|
NVCT
Nuvectis Pharma, Inc. Common Stock
|
$20.71
|
$154.27M | - | 45 | Compare |
|
CCCC
C4 Therapeutics, Inc.
|
$3.17
|
$153.02M | - | 52 | Compare |
|
CLYM
Climb Bio, Inc. Common Stock
|
$10.72
|
$133.50M | - | 67 | Compare |
|
STTK
Shattuck Labs, Inc. Common Stock
|
$5.63
|
$114.01M | - | 67 | Compare |
|
ANRO
Alto Neuroscience Inc.
|
$23.31
|
$110.20M | - | 71 | Compare |
|
ALXO
ALX Oncology Holdings Inc. Common Stock
|
$1.18
|
$96.93M | - | 59 | Compare |
|
ENTX
Entera Bio Ltd. Ordinary Shares
|
$2.99
|
$84.52M | - | 39 | Compare |
|
IMMX
Immix Biopharma, Inc. Common Stock
|
$8.43
|
$67.94M | - | 63 | Compare |
More BCAB Analysis
Data updated: Oct 22, 2026 | Industry: Biotechnology (SIC 2836)
223 stocks in this industry